Back

Can we predict adverse events in patients with heart failure with reduced ejection fraction submitted to cardiac resynchronization therapy? The role of MIBG scintigraphy.

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 5 - Nuclear cardiology, CMR and Computed Tomography Nuclear cardiology ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Madalena Coutinho Cruz

Hospital de Santa Marta, Lisbon (Portugal)

7 More presentations in this session

Presentation thumbnail
Detection of undiagnosed cardiac sarcoidosis by FDG-PET and SPECT among patients with Atrioventricular Block routinely followed in a pacemaker outpatient clinic
Doctor N. Serizawa (Tokyo, JP)
Abstract
Presentation thumbnail
Atherosclerotic plaque 18F-NaF uptake quantification methodology in high cardiovascular risk individuals: which method yields better results?
Doctor M. Santos (Coimbra, PT)
Abstract
Presentation thumbnail
Characterizing the role of human monocytes in myocardial infarction. In vivo and ex vivo imaging in a preclinical mouse model.
Ms J. Iking (Munster, DE)
Abstract Slides
Presentation thumbnail
Severe rest myocardial perfusion defects in experimental chronic Chagas cardiomyopathy correspond to viable hypoperfused myocardium: proof-of-concept study using prolonged dipyridamole administration
Associate Professor M. Simoes (Ribeirao Preto, BR)
Abstract Slides
Presentation thumbnail
Heterogeneity of myocardial FDG uptake is a typical feature in cardiac sarcoidosis: a study of 263 patients.
Associate Professor A. Loimaala (Helsinki, FI)
Abstract

Access the full session

Session thumbnail
Poster session 5 - Nuclear cardiology, CMR and Computed Tomography

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources